Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colombe Chappey

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
AIDS (London, England)|July 29, 2004
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistanceLisa Ross, Neil Parkin, Colombe Chappey, et al.
Nature Genetics|March 29, 2011
A systems analysis of mutational effects in HIV-1 protease and reverse transcriptaseTrevor Hinkley, João Martins, Colombe Chappey, et al.
Epidemics|March 1, 2011
Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environmentsJoão Z R Martins, Colombe Chappey, Mojgan Haddad, et al.
Plos One|February 8, 2011
Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacityAgnes C Paquet, John Baxter, Jodi Weidler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibilityLisa L Ross, Neil Parkin, Peter Gerondelis, et al.
Journal of Virological Methods|May 11, 2010
Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populationsMichael R Jordan, Mary Kearney, Sarah Palmer, et al.
The Journal of Infectious Diseases|January 6, 2007
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infectionPhilippe Flandre, Colombe Chappey, Anne Genevieve Marcelin, et al.
Journal of Virology|April 29, 2005
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype BSimon D W Frost, Yang Liu, Sergei L Kosakovsky Pond, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropismJeannette M Whitcomb, Wei Huang, Signe Fransen, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteersBarbara J Brennan, Brian Davies, Georgina Cirrincione-Dall, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
AIDS (London, England)|July 29, 2004
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistanceLisa Ross, Neil Parkin, Colombe Chappey, et al.
Nature Genetics|March 29, 2011
A systems analysis of mutational effects in HIV-1 protease and reverse transcriptaseTrevor Hinkley, João Martins, Colombe Chappey, et al.
Epidemics|March 1, 2011
Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environmentsJoão Z R Martins, Colombe Chappey, Mojgan Haddad, et al.
Plos One|February 8, 2011
Differences in reversion of resistance mutations to wild-type under structured treatment interruption and related increase in replication capacityAgnes C Paquet, John Baxter, Jodi Weidler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2006
Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibilityLisa L Ross, Neil Parkin, Peter Gerondelis, et al.
Journal of Virological Methods|May 11, 2010
Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populationsMichael R Jordan, Mary Kearney, Sarah Palmer, et al.
The Journal of Infectious Diseases|January 6, 2007
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infectionPhilippe Flandre, Colombe Chappey, Anne Genevieve Marcelin, et al.
Journal of Virology|April 29, 2005
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype BSimon D W Frost, Yang Liu, Sergei L Kosakovsky Pond, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2006
Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropismJeannette M Whitcomb, Wei Huang, Signe Fransen, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2012
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteersBarbara J Brennan, Brian Davies, Georgina Cirrincione-Dall, et al.
Pageof 4